SC
IDXX icon

Sapient Capital’s Idexx Laboratories IDXX Stock Holding History

Sapient Capital’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-391
Closed -$220K – 443
2026
Q1 		$220K Buy
391
+2
+0.5% +$1.28K ﹤0.01% 415
2025
Q4 		$265K Buy
+389
New +$265K ﹤0.01% 360
2024
Q4 		– Sell
-1,479
Closed -$747K – 393
2024
Q3 		$747K Sell
1,479
-43
-3% -$20.9K 0.02% 219
2024
Q2 		$742K Sell
1,522
-32,429
-96% -$16.3M 0.02% 193
2024
Q1 		$18.3M Buy
33,951
+4
+0% +$2.19K 0.41% 52
2023
Q4 		$18.8M Buy
+33,947
New +$15.9M 0.49% 50

Other funds holding IDXX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Sapient Capital's IDXX Position: Q2 2026 in Review

Sapient Capital sold out of Idexx Laboratories (IDXX) in Q2 2026, closing a stake of 391 shares — an estimated $220K sold.

Sapient Capital first reported a position in IDXX in Q4 2023 and held it in 6 quarters. The position peaked at $18.8M in Q4 2023. 1,300 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Sapient Capital reported no remaining Idexx Laboratories position as of Q2 2026 after selling out during the quarter.
  • Sapient Capital sold 391 Idexx Laboratories shares in Q2 2026, an estimated $220K.
  • Sapient Capital first reported a position in Idexx Laboratories in Q4 2023 and held it in 6 quarters.
  • Sapient Capital's Idexx Laboratories position peaked at $18.8M in Q4 2023.
  • 1,300 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Sapient Capital's 13F filing for Q2 2026, filed 9 Jul 2026.